During the past decade, CCR Brno, s.r.o conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCR Brno, s.r.o" #1 sponsor was "R-Pharm International, LLC" with 3 trials, followed by "Amzell" with 1 trials sponsored, "AnaptysBio, Inc." with 1 trials sponsored, "Bone Therapeutics S.A" with 1 trials sponsored and "Eupraxia Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCR Brno, s.r.o" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "CCR Brno, s.r.o" are "Rheumatoid Arthritis" (4 trials), "Osteoarthritis, Knee" (2 trials), "Ankylosing Spondylitis" (1 trials), "Arthritis" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "CCR Brno, s.r.o" in a lesser frequency.

Most popular intervention types in "CCR Brno, s.r.o" are "Drug" (11 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AMZ001" (1 trials), "Adalimumab 40mg q2w" (1 trials), "Comparator" (1 trials) and "Concomitant treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "CCR Brno, s.r.o" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CCR Brno, s.r.o". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CCR Brno, s.r.o, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CCR Brno, s.r.o, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".